Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00615_DB06414_nanopub.RAfJ9cXj-j4oJzAOuKNbggtcnl9fd1B0Dr_hh9S3nQdCc#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00615_DB06414 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00615_DB06414 label "DDI between Rifabutin and Etravirine - Etravirine may experience a decrease in serum concentration. It is recommended to monitor etravirine therapy for efficacy. The combination of rifabutin and etravirine therapy is contraindicated if a protease inhibitor which is ritonavir boosted is also being used. [drugbank_resource:DB00615_DB06414]" assertion.
- drugbank_resource:DB00615_DB06414 identifier "drugbank_resource:DB00615_DB06414" assertion.
- drugbank_resource:DB00615_DB06414 title "DDI between Rifabutin and Etravirine - Etravirine may experience a decrease in serum concentration. It is recommended to monitor etravirine therapy for efficacy. The combination of rifabutin and etravirine therapy is contraindicated if a protease inhibitor which is ritonavir boosted is also being used." assertion.
- drugbank:DB06414 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB06414 assertion.
- drugbank:DB00615 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00615_DB06414 assertion.